Who is sponsoring NCT03470363?

NCT03470363 is sponsored by University of Liege.

What drugs are being tested in NCT03470363?

Interventions in NCT03470363: Sevoflurane Volatile Liquid, Bupivacaine / SUFentanil.

What condition does NCT03470363 study?

NCT03470363 studies Knee Surgery With Tourniquet.

Is NCT03470363 still recruiting?

NCT03470363 is currently completed. Last updated 26 March 2020.

Last reviewed 2020-03-26 · How we verify

NCT03470363

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Spinal or Sevoflurane Anesthesia on Neutrophil Activation During Knee Surgery With Pneumatic Tourniquet

Completed NA Last updated 26 March 2020

What this trial tests

NA trial testing Sevoflurane Volatile Liquid in Knee Surgery With Tourniquet in 40 participants. Completed in 1 March 2018.

Timeline

1 January 2016

Primary endpoint
1 March 2018

1 March 2018

Quick facts

Lead sponsor	University of Liege
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	40
Start date	1 January 2016
Primary completion	1 March 2018
Estimated completion	1 March 2018

Drugs / interventions tested

Sevoflurane Volatile Liquid — full drug profile →
Bupivacaine / SUFentanil — full drug profile →

Conditions studied

Knee Surgery With Tourniquet — all drugs for Knee Surgery With Tourniquet →

Sponsor

University of Liege

Who can join

18 and older, any sex, with Knee Surgery With Tourniquet. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of study : Assessement of neutrophil activation during ischemia reperfusion associated with tourniquet use for total knee arthroplasty. This activation was compared in a group of patient scheduled for spinal anesthesia and for sevoflurane anesthesia

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03470363 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 26 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03470363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing